Skip to main content

Publication

Home | Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis
Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis
Walsh, CAE; Minnock,P; Slattery, C; Kennedy, N; Pang, F; Veale, DJ; Bresnihan, B; FitzGerald , O
(2007)
Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis in Rheumatology